Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




Master Class Teaches HbA1c, Hb, Glucose, and Lactate Measurement

By LabMedica International staff writers
Posted on 01 Oct 2013
A global point-of-care (POC) diagnostics business, announced that it would support and train its customers in the capabilities of new and existing analyzers for HbA1c, hemoglobin, glucose, and lactate testing.

EKF Diagnostics (Cardiff, UK) is delivering the 2013 Master Class series to provide delegates with a comprehensive understanding of the company's range of blood analyzers and the conditions that have been developed to diagnose and monitor, including diabetes and anemia. More...
Since January, delegates from over 50 distributor companies in 30 different countries have gained hands-on experience and training in new POC instruments and applications.

Following successful events in London, Dubai, Thailand, and China, the Master Class Series will continue in Mexico City, on October 3 and 4, 2013. At each event the interactive sessions showcase new products, such as the Quo-Lab HbA1c analyzer as well as new applications for existing products, including Hemo Control, Biosen, and Lactate Scout+. Delegates are encouraged to share their knowledge and experiences of selling IVD products in a competitive marketplace.

Delegates have found the EKF Master Classes to be very useful, appreciating the direct contact with EKF experts and opportunity for additional training. For example, Gigi Veslino, MRL Cybertec Corporation, attended the Master Class in Shenzhen, China, and said, “The EKF Master Class was very informative, yet at the same time it was simple and easy to understand. This will certainly be a great help for us when explaining the key features and benefits of EKF products to our clients.”

She continued, “The event also provided an ideal opportunity for EKF distributors to share knowledge and strategies with one another. We look forward to attending future Master Classes on new products and updates, to ensure that we maintain our knowledge of EKF’s technologies.”

For details of future EKF Master Classes to be held worldwide, please see Related LInks below.

EKF Diagnostics’ expertise covers POC diagnostics in vitro diagnostics chain, from fermentation and enzyme production, to liquid reagent manufacture, design, and building of diagnostic devices, and distribution of rapid test kits for infectious diseases and pregnancy. In March 2013, EKF set up a new division to focus on molecular and companion diagnostics. EKF Molecular Diagnostics develops technologies for cancer gene detection The EKF analyzer range is used widely in GP surgeries, pharmacies, blood banks, sports clinics, hospitals, and laboratories.

Related Links:

EKF Diagnostics
EKF Diagnostics 2013 Master classes



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.